肝癌衍生生长因子在肿瘤中的表达及其相关信号通路

国际肿瘤学杂志››2017,Vol. 44››Issue (3): 193-195.doi:10.3760/cma.j.issn.1673422X.2017.03.009

肝癌衍生生长因子在肿瘤中的表达及其相关信号通路

杨飞龙,李大伟,任巨超,闫磊,周尊林,刘海南,徐忠华

250012 济南，山东大学齐鲁医院泌尿外科

出版日期:2017-03-08发布日期:2017-02-28
通讯作者:李大伟 E-mail:lidaweimd@aliyun.com
基金资助:

国家自然科学基金（81502213、81372335）；山东省自然科学基金

（ZR2015HM046）

Expression of hepatomaderived growth factor in tumor and its related signaling pathway

Yang Feilong, Li Dawei, Ren Juchao, Yan Lei, Zhou Zunlin, Liu Hainan, Xu Zhonghua

Department of Urological Surgery, Qilu Hospital of Shandong University, Ji′nan 250012, China

Online:2017-03-08Published:2017-02-28
Contact:Li Dawei E-mail:lidaweimd@aliyun.com
Supported by:

National Natural Science Foundation of China (81502213,

81372335); Natural Science Foundation of Shandong Province of China

(ZR2015HM046)

摘要/Abstract

摘要：Recent studies find that the expression of hepatomaderived growth factor (HDGF) is closely correlated with the tumorigenesis, progression, metastasis, therapy and prognosis of various malignancies. Though the mechanism of the interaction of HDGF and tumors is still unclear, the research of HDGF serving as a tumor marker in malignancies and a new target for tumor treatment has become a hotspot in the research of tumor.

杨飞龙,李大伟,任巨超,闫磊,周尊林,刘海南,徐忠华. 肝癌衍生生长因子在肿瘤中的表达及其相关信号通路[J]. 国际肿瘤学杂志, 2017, 44(3): 193-195.

Yang Feilong, Li Dawei, Ren Juchao, Yan Lei, Zhou Zunlin, Liu Hainan, Xu Zhonghua. Expression of hepatomaderived growth factor in tumor and its related signaling pathway[J]. Journal of International Oncology, 2017, 44(3): 193-195.

参考文献

［1］ Bao C, Wang J, Ma W, et al. HDGF: a novel jackofalltrades in cancer［J］. Future Oncol, 2014, 10(16): 2675-2685. DOI: 10.2217/FON.14.194. ［2］ Lin YW, Li CF, Chen HY, et al. The expression and prognostic significance of hepatomaderived growth factor in oral cancer［J］. Oral Oncol, 2012, 48(7): 629-635. DOI: 10.1016/j.oraloncology.2012.01.014. ［3］ Chen B, Huang T, Jiang J, et al. miR141 suppresses proliferation and motility of gastric cancer cells by targeting HDGF［J］. Mol Cell Biochem, 2014, 388(12): 211-218. DOI: 10.1007/s1101001319123. ［4］ Lian J, Tang J, Shi H, et al. Positive feedback loop of hepatomaderived growth factor and betacatenin promotes carcinogenesis of colorectal cancer［J］. Oncotarget, 2015, 6(30): 29357-29374. DOI: 10.18632/oncotarget.4982. ［5］ Guo S, Liu HD, Liu YF, et al. Hepatomaderived growth factor: a novel prognostic biomarker in intrahepatic cholangiocarcinoma［J］. Tumour Biol, 2015, 36(1): 353-364. DOI: 10.1007/s1327701426510. ［6］ Meng J, Xie W, Cao L, et al. shRNA targeting HDGF suppressed cell growth and invasion of squamous cell lung cancer［J］. Acta Biochim Biophys Sin (Shanghai), 2010, 42(1): 52-57. ［7］ Liu XJ, Liu WL, Yang FM, et al. Hepatomaderived growth factor predicts unfavorable prognosis of epithelial ovarian cancer［J］. Onco Targets Ther, 2015, 8: 2101-2109. DOI: 10.2147/OTT.S85660. ［8］ Wang L, Jiang Q, Hua S, et al. High nuclear expression of HDGF correlates with disease progression and poor prognosis in human endometrial carcinoma［J］. Dis Markers, 2014, 2014: 298795. DOI: 10.1155/2014/298795. ［9］ Chen SC, Kung ML, Hu TH, et al. Hepatomaderived growth factor regulates breast cancer cell invasion by modulating epithelialmesenchymal transition［J］. J Pathol, 2012, 228(2): 158-169. DOI: 10.1002/path.3988. ［10］ Yang Y, Li H, Zhang F, et al. Clinical and biological significance of hepatomaderived growth factor in Ewing′s sarcoma［J］. J Pathol, 2013, 231(3): 323-334. DOI: 10.1002/path.4241. ［11］ Song Y, Hu Z, Long H, et al. A complex mechanism for HDGFmediated cell growth, migration, invasion, and TMZ chemosensitivity in glioma［J］ . J Neurooncol, 2014, 119(2): 285-295. DOI: 10.1007/s1106001415124. ［12］ Guo H, Li W, Zheng T, et al. MiR195 targets HDGF to inhibit proliferation and invasion of NSCLC cells［J］. Tumour Biol, 2014, 35(9): 8861-8866. DOI: 10.1007/s1327701421530. ［13］ Ke Y, Zhao W, Xiong J, et al. Downregulation of miR16 promotes growth and motility by targeting HDGF in nonsmall cell lung cancer cells ［J］. FEBS Lett, 2013, 587(18): 3153-3157. DOI: 10.1016/j.febslet.2013.08.010. ［14］ Bao CH, Wang XT, Ma W, et al. Irradiated fibroblasts promote epithelialmesenchymal transition and HDGF expression of esophageal squamous cell carcinoma［J］. Biochem Biophys Res Commun, 2015, 458(2): 441 -447. DOI: 10.1016/j.bbrc.2015.02.001. ［15］ Yang Y, Zhen T, Zhang F, et al. p53 and hepatomaderived growth factor expression and their clinicopathological association with Ewing family tumour［J］. J Clin Pathol, 2014, 67(3): 235-242. DOI: 10.1136/jclinpath2013201705. ［16］ Thirant C, GalanMoya EM, Dubois LG, et al. Differential proteomic analysis of human glioblastoma and neural stem cells reveals HDGF as a novel angiogenic secreted factor［J］. Stem Cells, 2012, 30(5): 845-853. DOI: 10.1002/stem.1062. ［17］ Tsai HE, Wu JC, Kung ML, et al. Upregulation of hepatomaderived growth factor facilitates tumor progression in malignant melanoma［J］. PLoS One, 2013, 8(3): e59345. DOI: 10.1371/journal.pone.0059345. ［18］ Tsai HE, Liu GS, Kung ML, et al. Downregulation of hepatomaderived growth factor contributes to retarded lung metastasis via inhibition of epithelialmesenchymal transition by systemic POMC gene delivery in melanoma［J］. Mol Cancer Ther, 2013, 12(6): 1016-1025. DOI: 10.1158/1535 7163.MCT120832. ［19］ Sedlmaier A, Wernert N, Gallitzendrfer R, et al. Overexpression of hepatomaderived growth factor in melanocytes does not lead to oncogenic transformation［J］. BMC Cancer, 2011, 11: 457. DOI: 10.1186/1471240711 457. ［20］ Guo Z, He Y, Wang S, et al. Various effects of hepatomaderived growth factor on cell growth, migration and invasion of breast cancer and prostate cancer cells［J］. Oncol Rep, 2011, 26(2): 511-517. DOI: 10.3892/or.2011.1295. ［21］ Bao CH, Liu K, Wang XT, et al. Prognostic role of hepatomaderived growth factor in solid tumors of Eastern Asia: a systematic review and meta analysis［J］. Asian Pac J Cancer Prev, 2015, 16(5): 1803-1811. ［22］ Kung ML, Tsai HE, Hu TH, et al. Hepatomaderived growth factor stimulates podosome rosettes formation in NIH/3T3 cells through the activation of phosphatidylinositol 3kinase/Akt pathway［J］. Biochem Biophys Res Commun, 2012, 425(2): 169-176. DOI: 10.1016/j.bbrc.2012.07.060. ［23］ Li D, Han Z, Liu J, et al. Upregulation of nucleus HDGF predicts poor prognostic outcome in patients with penile squamous cell carcinoma bypass VEGFA and Ki67［J］. Med Oncol, 2013, 30(4): 702. DOI: 10.1007/s1203201307029. ［24］ Li SZ, Zhao YB, Cao WD, et al. The expression of hepatomaderived growth factor in primary central nervous system lymphoma and its correlation with angiogenesis, proliferation and clinical outcome［J］. Med Oncol, 2013, 30(3): 622. DOI: 10.1007/s1203201306228. ［25］ Yu Y, Shen H, Yu H, et al. Systematic proteomic analysis of human hepotacellular carcinoma cells reveals molecular pathways and networks involved in metastasis［J］. Mol Biosyst, 2011, 7(6): 1908-1916. DOI: 10.1039/c0mb00265h. ［26］ Zhang J, Chen N, Qi J, et al. HDGF and ADAM9 are novel molecular staging biomarkers, prognostic biomarkers and predictive biomarkers for adjuvant chemotherapy in surgically resected stage Ⅰ nonsmall cell lung cancer［J］. J Cancer Res Clin Oncol, 2014, 140(8): 1441-1449. DOI: 10.1007/s0043201416872. ［27］ Sun B, Gu X, Chen Z, et al. MiR610 inhibits cell proliferation and invasion in colorectal cancer by repressing hepatomaderived growth factor ［J］. Am J Cancer Res, 2015, 5(12): 3635-3644.

[1]	陈红健, 张素青.血清miR-24-3p、H2AFX与肝癌患者临床病理特征及术后复发的关系研究[J]. 国际肿瘤学杂志, 2024, 51(6): 344-349.
[2]	彭琴, 蔡玉婷, 王伟.KPNA2在肝癌中的研究进展[J]. 国际肿瘤学杂志, 2024, 51(3): 181-185.
[3]	孙国宝, 杨倩, 庄庆春, 高斌斌, 孙晓刚, 宋伟, 沙丹.结直肠癌肝转移组织病理学生长方式研究进展[J]. 国际肿瘤学杂志, 2024, 51(2): 114-118.
[4]	向玉玲, 谭佳杰, 熊远果, 赵丽蓉, 黎晨, 张洪.脱水淫羊藿素对肝癌细胞增殖、迁移和凋亡的影响[J]. 国际肿瘤学杂志, 2023, 50(9): 513-519.
[5]	李佳璇, 封颖璐.糖皮质激素受体在肝癌细胞生长中的作用机制[J]. 国际肿瘤学杂志, 2023, 50(4): 241-243.
[6]	和婷, 王希, 张惠中, 刘昕阳, 王会平, 董轲.血清TIM-3对肝癌患者诊断价值的研究[J]. 国际肿瘤学杂志, 2022, 49(9): 537-542.
[7]	张玉敏, 赵现伟, 何前进, 陈杰能.超声造影联合血清CXCL8、CXCR2在原发性肝癌经导管动脉化疗栓塞术后疗效评估中的价值分析[J]. 国际肿瘤学杂志, 2022, 49(10): 592-596.
[8]	狄伟华, 赵雪梅.DNA损伤修复在肝癌中的研究进展[J]. 国际肿瘤学杂志, 2022, 49(10): 635-638.
[9]	杜佳航, 陈栋, 陈耀庭.三氧化二砷抗肝癌机制及其在肝癌治疗中的研究[J]. 国际肿瘤学杂志, 2021, 48(9): 572-.
[10]	韩保俊.组蛋白乙酰转移酶P300在肝癌组织中的表达及其临床意义[J]. 国际肿瘤学杂志, 2021, 48(7): 415-419.
[11]	张玉元, 李臻, 詹鹏超, 李鑫, 叶书文, 王彩鸿, 刘杨.肝癌标志物研究进展[J]. 国际肿瘤学杂志, 2021, 48(4): 241-245.
[12]	熊琳, 张修云, 张小余, 黎越, 徐细明.IWR-1-endo通过抑制Wnt通路影响肝癌细胞的迁移和增殖[J]. 国际肿瘤学杂志, 2021, 48(12): 711-715.
[13]	刘俊国, 张金卷, 王毅军.ALPPS中肝脏离断技术变异的临床应用进展[J]. 国际肿瘤学杂志, 2020, 47(8): 492-495.
[14]	张伟, 殷海涛, 周冲, 李向阳, 郭林.甲磺酸阿帕替尼联合卡瑞利珠单抗治疗原发性肝癌伴肺转移一例[J]. 国际肿瘤学杂志, 2020, 47(8): 510-512.
[15]	辛瑞强, 宋晓萍, 张帆, 孙莹, 王涛, 孙伟.SUMO调控XBP1介导的内质网应激对肝癌进展的影响机制[J]. 国际肿瘤学杂志, 2020, 47(7): 397-403.